NY-NMS-CAPITAL/LBN
DirectMed Parts & Service (“DirectMed”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired LBN Medical (“LBN” or the “Company”). Terms of the transaction were not disclosed.
Headquartered in Aalborg, Denmark, LBN is a leading reseller of aftermarket diagnostic imaging equipment to customers around the world. LBN sells complete systems and parts covering more than fifteen brands, including major OEMs such as Canon, GE, Hologic, Siemens, and Philips. The Company was founded in 2003 by CEO Lars Braun Nielsen and has since grown to more than 50 employees at facilities in Denmark and Egypt.
Lars Braun Nielsen, CEO and Founder of LBN, stated, “Brad and the DirectMed team have outlined their mission to extend the life of medical imaging equipment to improve access, reduce waste, and lower healthcare costs. We are thrilled to be a part of this endeavor, and to work with the DirectMed team and NMS to accelerate our growth. The partnership with DirectMed provides LBN with tremendous resources to provide an even higher level of service and expertise to our customers, including a greater breadth and depth of parts and technical support.”
“We have known LBN Medical for several years and believe they are the logical company to help DirectMed expand our parts business outside of North America. Their distribution team – which speaks 21 different languages, with sales history in over 60 countries, and employs experts across seven modalities – is the perfect complement to our business,” said Brad de Koning, DirectMed’s President & CEO. “Acquiring LBN Medical begins an exciting new chapter for DirectMed, with the addition of system sales to our customer base, and for LBN Medical, who will now stock and have access to over 10,000 unique part numbers to support theirs.”
David Peterson, Managing Director at NMS, stated, “Since we partnered with the DirectMed team in June 2021, one of our primary areas of focus has been expanding our geographic coverage. Providers around the world are looking for cost-effective solutions to acquire and maintain equipment as they continue to grow their practice. The combination of DirectMed and LBN supports that exact need in the marketplace. We are very excited to be partnering with the LBN team for the next phase of our business and look forward to leveraging DirectMed’s experience in parts and related repairs to accelerate our growth internationally.”
Accura and Greenberg Traurig provided legal advice to DirectMed.
About LBN:
LBN Medical is a leading reseller of aftermarket medical imaging equipment to customers around the world. LBN sells equipment and parts covering more than fifteen brands, including major OEMs such as Canon, GE, Siemens, and Philips. The Company was founded in 2003 by CEO Lars Braun Nielsen, and has since grown to an organization of more than 50 associates at facilities in Denmark and Egypt. For additional information on LBN, please visit the firm's website at LBNmedical.com
.
About DirectMed:
DirectMed Parts & Service is the largest independent diagnostic imaging parts supplier specializing in MRI and CT machines with over 60,000 parts in stock. An ISO 13485 certified company, DirectMed repairs, supports and sells GE, Siemens, and Philips parts to healthcare networks, imaging centers and independent service organizations ("ISOs") around the world. For additional information on DirectMed, please visit the firm's website at directmedparts.com
.
About NMS Capital:
NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from Goldman Sachs’ Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Business Services and Healthcare Services. For additional information on NMS, please visit the firm's website at nms-capital.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220204005064/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 19:00:00 CEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 14:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 12:50:00 CEST | Press release
Revenue of $8.49 billion decreased 3% year on year GAAP EPS of $0.58 decreased 22% year on year EPS, excluding charges and credits, of $0.72 decreased 4% year on year Net income attributable to SLB of $797 million decreased 25% year on year Adjusted EBITDA of $2.02 billion decreased 2% year on year Cash flow from operations of $660 million increased $333 million year on year Board approved quarterly cash dividend of $0.285 per share SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9%
Corona, The World’s Most Valuable Beer Brand1, Announces Its 100-Year Anniversary with Global Celebration25.4.2025 10:00:00 CEST | Press release
Brand Invites The World to Join the Celebration with Experiences at the Most Epic Beaches on EarthGlobal “Corona 100” Platform Launches with a Legendary Concert at Copacabana Beach, Featuring One of the World’s Top Musical Artists with Millions in Attendance Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive l
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 09:28:00 CEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom